Zhao Lanbo, Cong Rong, Pan Zhenni, Xue Yan, Li Yaling, Li Qiling
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China.
The Second Clinical Medical College of Lanzhou University, Lanzhou University, Lanzhou, 730030, Gansu, China.
Surg Endosc. 2025 Feb;39(2):1362-1371. doi: 10.1007/s00464-025-11533-7. Epub 2025 Jan 13.
Robotic-assisted laparoscopic single-site hysterectomy is popular among patients and surgeons due to good cosmetic outcomes and fast recovery. However, questions remain such as loss of triangulation and instrument collision. Our aim is to test the feasibility and safety of a purpose-designed single-site robotic surgical platform mainly in hysterectomies.
We retrospectively collected patients who had undergone hysterectomy by SHURUI (SR-ENS-600) robotic surgical system in the First Affiliated Hospital of Xi'an Jiaotong University. Initial cases as control were also collected including da Vinci single-site (IS4000) and multi-port (IS3000 and IS4000) hysterectomies performed by the same surgical team. The main outcome was surgical feasibility rate (valid surgeries/total cases × 100%). Short-term post-operative outcomes and complications were recorded and compared between three groups.
From Dec, 2nd, 2023 to Mar, 1st, 2024, 19 cases of hysterectomies were enrolled, including 6 myomas, 2 adenomyosis, 9 cervical high-grade squamous intraepithelial lesion/stage Ia1 cancers, and 2 stage Ia endometrial cancers. Seventeen cases of da Vinci single-site surgeries and 20 cases of multi-ports surgeries were also included for comparation. Intra-operative bleeding volume was significantly lower in SHURUI group compared with da Vinci single-site and multi-ports groups (40.5 mL vs 47.4 mL vs 58.5 mL, P = 0.046 and 0.028). Post-operative time to flatus was also shorter in SHURUI group compared with da Vinci single-site and multi-port surgeries (22.9 h vs. 33.5 h vs. 28.6 h, P = 0.054 and 0.001). Follow-up for SHURUI group lasted for 3 months with no complications.
SHURUI robotic surgery was feasible and safe in hysterectomies. It also had comparable outcomes with da Vinci robotic platform and approaches.
机器人辅助腹腔镜单孔子宫切除术因美容效果好和恢复快而受到患者和外科医生的欢迎。然而，仍存在一些问题，如三角定位丧失和器械碰撞。我们的目的是主要在子宫切除术中测试一种专门设计的单孔机器人手术平台的可行性和安全性。
我们回顾性收集了在西安交通大学第一附属医院接受SHURUI（SR-ENS-600）机器人手术系统子宫切除术的患者。还收集了初始病例作为对照，包括由同一手术团队进行的达芬奇单孔（IS4000）和多孔（IS3000和IS4000）子宫切除术。主要结局是手术成功率（有效手术数/总病例数×100%）。记录并比较三组患者术后短期结局和并发症。
2023年12月2日至2024年3月1日，纳入19例子宫切除术患者，其中子宫肌瘤6例，子宫腺肌病2例，宫颈高级别鳞状上皮内病变/Ⅰa1期癌9例，Ⅰa期子宫内膜癌2例。还纳入了17例达芬奇单孔手术和20例多孔手术进行比较。SHURUI组术中出血量明显低于达芬奇单孔组和多孔组（40.5 mL对47.4 mL对58.5 mL，P = 0.046和0.028）。SHURUI组术后排气时间也比达芬奇单孔手术和多孔手术短（22.9小时对33.5小时对28.6小时，P = 0.054和0.001）。SHURUI组随访3个月，无并发症发生。
SHURUI机器人手术在子宫切除术中是可行且安全的。其效果与达芬奇机器人平台及手术方式相当。
